Stocks and Investing
Stocks and Investing
Tue, March 22, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 21, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Terry Tillman Downgraded (BLND) to Hold and Held Target at $7.5 on, Mar 21st, 2022
Terry Tillman of Truist Securities, Downgraded "Blend Labs, Inc." (BLND) to Hold and Held Target at $7.5 on, Mar 21st, 2022.
Terry has made no other calls on BLND in the last 4 months.
There are 4 other peers that have a rating on BLND. Out of the 4 peers that are also analyzing BLND, 1 agrees with Terry's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ryan Tomasello of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $12 on, Monday, February 14th, 2022
These are the ratings of the 3 analyists that currently disagree with Terry
- Michael Turrin of "Wells Fargo" Maintained at Buy with Decreased Target to $11 on, Tuesday, March 15th, 2022
- Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $10 on, Tuesday, January 25th, 2022
- Arvind Ramnani of "Piper Sandler" Maintained at Buy with Decreased Target to $10 on, Thursday, January 13th, 2022
Contributing Sources